Signal Override: Precision Editing of Protein Kinase Cα in Heart Failure

Read full text Summarise with VIRAT
Authors: Sandra Ratnavadivel, Jing Zhang, Farah Sheikh
Cited by: 0
References: 14

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

heart failure; base editing; cardiac muscle; protein kinase C-alpha; signaling Heart failure with reduced ejection fraction (HFrEF) is a progressive clinical syndrome defined by diminished cardiac output (ejection fraction ≤40%) and accompanied by neurohormonal activation and impaired β1-adrenergic receptor sensitization and signaling 1,2 .Although guideline-directed therapies have significantly advanced clinical management, through the use of angiotensin-receptor-neprilysin inhibitors, β-blockers, and sodium-glucose cotransporter-2 inhibitors, these agents provide only partial control, and HFrEF remains the leading global cause of mortality 3 .Importantly, these therapies primarily target cardiorenal-metabolic pathways and do not correct the underlying intracellular signaling defects that drive diminished cardiac contractility 4 .Among these dysregulated pathways, maladaptive protein kinase activity has emerged as a critical driver of heart failure progression 5 .Within this landscape, protein kinase-α (PKCα) plays a pivotal role in regulating cardiomyocyte contractility.PKCα can indirectly regulate sarco-endoplasmic reticulum ATPase (SERCA) activity, disrupting calcium cycling and systolic force generation, and positioning PKCα as a central mediator of contractile dysfunction 6 .PKCα also phosphorylates myofilament proteins such as cardiac troponin I (cTnI), cTnT, titin, and myosin binding protein C, which leads to decreased myofilament Ca 2+ sensitivity and cardiomyocyte contractility 7 .In addition, PKCα can modulate L-type Ca 2+ channel activity through phosphorylation of the α1c subunit 8 .Prkca is also the most predominant PKC isoform in the heart, highly expressed in the fetal and neonatal heart and downregulated in adult heart tissue 9 .PKCα levels are elevated in failing human hearts 10 and following myocardial infarction 11 , suggesting a reversion towards a neonatal-like signaling state 9 , marked by phospho-activation at T497 12 .Although PKCα inhibition has been proposed

Fields of Study & Subjects

CRISPR and Genetic Engineering Cardiac electrophysiology and arrhythmias Cardiomyopathy and Myosin Studies

Publication details

Journal / source
Circulation Research
Volume
138
Issue
7
Pages
e328024–e328024
Publication date
26 March 2026
Language
EN